Positron Azione

Positron Debiti verso fornitori

Il Debiti Commerciali di Positron (POSC) al 18 ago 2026 è 849.000,00 USD.

Debiti verso fornitori

849.000,00USD

Ultimo aggiornamento:

Debiti Commerciali di Positron ammonta a 2026 849.000,00 USD. Debiti Commerciali di Positron ammontava a 2025 - USD. Diminuisce del % inferiore rispetto all'anno precedente.
Access this data via the Eulerpool API

Positron Analisi delle Azioni

Cosa fa Positron? Positron Corp is a company in the medical technology industry specializing in the development of PET (positron emission tomography) systems and solutions. The company was founded in 1983 as Positron Corporation with headquarters in Houston, Texas, USA. Initially focused on research and development of technologies for radiation therapy, the company shifted its focus to PET imaging and became a pioneer in the field. Positron Corp's business model is based on selling PET systems and related solutions and services to medical facilities and organizations. The company offers both stationary and mobile systems for various applications such as cancer diagnostics. Positron Corp is divided into different divisions specializing in different areas of PET technology, including the development, production, and distribution of PET modules, systems, and software solutions. The flagship product of Positron Corp is the Total-body PET module, which enables complete imaging of the human body and is unique in the medical field. The module was designed to meet the need for whole-body imaging in cancer diagnostics and offers patients a non-invasive way to monitor cancer cells and metastases. In addition to the Total-body PET module, the company also offers specialized solutions for various areas of PET imaging, including a portable PET scanner suitable for use in emergency rooms or intensive care units. Another area of Positron Corp is the development and production of radiation therapy products. The company has developed a range of radiopharmaceuticals that can be used in cancer treatment, including radioisotopes such as fluorine-18, used for labeling molecules in cancer diagnostics, and yttrium-90, used in radiation therapy for the treatment of liver tumors. To ensure that its products remain at the forefront of technology, Positron Corp is heavily involved in research and development. The company collaborates closely with leading research and development companies to develop innovative solutions and technologies that meet the demands of the medical technology industry. Overall, Positron Corp has established itself as a key player in the medical technology industry, developing innovative solutions and technologies for PET imaging and radiation therapy. The company is committed to improving the standard of medical diagnostics and treatment, contributing to the improvement of healthcare. Positron è una delle aziende più popolari su Eulerpool.com.

Domande frequenti su Positron azioni

Debiti Commerciali di Positron è 849.000,00 USD nel 2026.

Su Eulerpool è possibile consultare lo sviluppo storico completo del Positron di Debiti Commerciali dal 2006, con valori annuali, grafici e analisi dettagliate.

I debiti commerciali rappresentano il denaro dovuto ai fornitori per beni e servizi ricevuti. È un componente fondamentale della gestione del capitale di esercizio.

Il USD di Debiti Commerciali è un fattore chiave per gli investitori. I cambiamenti in questa metrica possono segnalare il miglioramento o il deterioramento dei fondamentali, impattando direttamente il prezzo delle azioni. Su Eulerpool puoi tracciare il Positron di Debiti Commerciali storicamente e in tempo reale.

Access this data via the Eulerpool API

Bilancio — Positron

Tutte le Metriche Finanziarie — Positron